{"organizations": [], "uuid": "cb58885eb0ef0007f5cbb2e8b25a857e51f1f69d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180130.html", "section_title": "Archive News &amp; Video for Tuesday, 30 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zimmer-biomet-holdings-reports-q4/brief-zimmer-biomet-holdings-reports-q4-eps-of-6-16-idUSASB0C2Y4", "country": "US", "domain_rank": 408, "title": "BRIEF-Zimmer Biomet Holdings Reports Q4 EPS Of $6.16", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T20:07:00.000+02:00", "replies_count": 0, "uuid": "cb58885eb0ef0007f5cbb2e8b25a857e51f1f69d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zimmer-biomet-holdings-reports-q4/brief-zimmer-biomet-holdings-reports-q4-eps-of-6-16-idUSASB0C2Y4", "ord_in_thread": 0, "title": "BRIEF-Zimmer Biomet Holdings Reports Q4 EPS Of $6.16", "locations": [], "entities": {"persons": [{"name": "zimmer", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biomet holdings inc", "sentiment": "negative"}, {"name": "biomet holdings", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "biomet", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 30 (Reuters) - Zimmer Biomet Holdings Inc:\n* ZIMMER BIOMET ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 RESULTS\n* Q4 ADJUSTED EARNINGS PER SHARE $2.10 * Q4 EARNINGS PER SHARE $6.16 * Q4 SALES $2.074 BILLION VERSUS I/B/E/S VIEW $2.03 BILLION\n* Q4 EARNINGS PER SHARE VIEW $2.10 -- THOMSON REUTERS I/B/E/S\n* SEES Q1 2018 EARNINGS PER SHARE $0.73 TO $0.88 * SEES Q1 2018 REVENUE $1.955 BILLION TO $1.995 BILLION * ZIMMER BIOMET - EXPECTS DILUTED EPS FOR Q1 2018 TO BE IN RANGE OF $1.84 TO $1.91 ON ADJUSTED BASIS\n* ZIMMER BIOMET - EPS FOR Q4 INCLUDED ONE-TIME TAX BENEFIT OF ABOUT $6.40 PER SHARE RESULTING FROM RECENTLY ENACTED U.S. TAX REFORMâ€‹\n* Q1 EARNINGS PER SHARE VIEW $2.02, REVENUE VIEW $2.01 BILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-30T20:07:00.000+02:00", "crawled": "2018-01-31T16:10:30.003+02:00", "highlightTitle": ""}